Tag:
Pacific Biosciences
Latest Headlines
Latest Headlines
Eric Schadt leading biotech computing charge in NYC
In the biotech game, New York City doesn't hold a candle to Boston or San Francisco. But if anyone can change that perception, perhaps it's Eric Schadt, the chief scientist of Pacific Biosciences (
Sequencing leaders want industry standards to govern decoded DNA
The math on sequencing's growing reach is pretty simple. In 2009, a few dozen genomes were sequenced. Last year the genes of some 1,700 people were sequenced. This year, analysts say the number will
PacBio reaches for cloud tech amid biz slump
Pacific Biosciences ( $PACB ) wants to offer users of its sequencing machine new cloud computing capabilities amid struggles to hit sales targets for its cutting edge system for quickly and cheaply...
Pacific Biosciences axes 130 jobs as it slams brakes on spending
Creating a company on the bleeding edge of a new technology can cut both ways. After the initial demand for its highly touted sequencing tech fell short of expectations, Menlo Park, CA-based Pacific
PacBio fosters software community with 3rd-gen sequencer release
With the commercial release of Pacific Biosciences' third-generation sequencer in April come new opportunities for software vendors to provide tools to enhance the utility of the data provided by the
PacBio's Schadt leading $100M effort at Mt. Sinai
Dr. Eric E. Schadt ( photo ), a rock star of sorts in genetics circles and chief scientist at Pacific Biosciences ( $PACB ), is set to lead a new genomics research group at Mount Sinai in New York. Menlo
PacBio starts shipping Real-Time sequencing machine
This week Pacific Biosciences--the biotech superstar that has raised hundreds of millions in venture capital and launched an IPO --started shipping its PacBio RS system. According to a release, the
Roche, Novartis make MIT innovators list
MIT's Technology Review has unveiled its list of the top 50 innovators, and nine life science companies have made the list. Roche and Novartis are representing Big Pharma this year. Roche's work
2010: The little IPO engines that usually couldn't
Every year everybody who's anybody in biotech--and a lot who aren't--goes to the JP Morgan conference in San Francisco in January. This year the talk quickly turned bullish as biotech execs and
The Scientist picks the top 10 tech products in life sciences
The Scientist magazine recently convened a panel of experts in the life sciences industry to take a hard look at the latest technological advances in the field, and Pacific Biosciences emerged as the
